Patients with cancer, particularly those undergoing active treatment, frequently experience thromboembolic events. Despite the availability of many guidelines for VTE prophylaxis, data demonstrates that there is a discordance between guidelines and practice. In point of fact, VTE is a leading cause of morbidity in patients with cancer.
To support our staff in the furtherance of excellent treatment provided by City of Hope, the Department of Continuing Medical Education will release an accredited series of educational interventions, the focus of which will be the prevention and decrease of venous thromboembolic events (VTE).
This series has been made possible by support from the Unihealth Foundation.
On the Go
Hear what experts have to say about VTE. The following can be completed in 20 minutes or less.
- VTE Scope of the Problem
- Guidelines and Recommendations
- City of Hope Anticoagulation Group
- Pharmacologic Thromboprophylaxis
- Clot Busters: The RN's Role in Preventing and Managing Venous Thromboembolitic Events
- Risk Assessment and Challenges
- CVAD and VTE: "PICC"ing Against the Odds
- Safety Considerations in VTE
- Interventions to Prevent Venous Thromboembolic Disease, (VTE) in a Patient Population with Contraindication to Anticoagulation
- Strategies to Improve VTE Prophylaxis
- Overcoming Barriers: An Illustrative Case
- 2014 City of Hope Systems in Place to Improve VTE Prophylaxis
- The Interventional Management of Venous Thromboembolism: When Anticoagulation Isn't Enough
- Prediction of Risk and Development of Preventative Management Strategies for Patients at Risk for Venous Thrombolic Events
To receive AMA PRA Category 1 Credit(s)TM you must:
- Register for each individual program.
- View course materials.
- Pass each post test with 70 percent or better.
- Complete the activity evaluation.
If you have any questions regarding credits, please contact the Department of Continuing Medical Education at 626-256-4673, ext. 65622, or [email protected].